1 – 5 of 5
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2022
- 
                        Mark
        Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Prognostic and predictive biomarkers in metastatic colorectal cancer constant and evolutionary perspectives
    (2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
    (2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.220-220- Contribution to journal › Published meeting abstract
 
- 2017
- 
                        Mark
        High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
    
    - Contribution to journal › Article
 
